Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
Recalled November 13, 2019 · FDA recall D-0182-2020 · Dr. Reddy's Laboratories
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
N/A
Sold at
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →